Roche opens the weekend with SMI context, shares at 336 francs
27.06.2026 - 09:26:34 | ad-hoc-news.deBy Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-27, 07:26.
Roche (CH0012032048) starts the weekend with Swiss market context. Roche Holding AG shares traded at 336.00 Swiss francs on 2026-06-26 on Swiss Exchange, according to MarketScreener and Hargreaves Lansdown.
Swiss trading backdrop
The latest Swiss session left Roche in a steady range near 336 francs, after a 0.21 percent rise on 26 June, MarketScreener shows. The broader SMI also ended the session with moderate losses after a record high, which keeps Roche tied to the Swiss large-cap benchmark. MarketScreener price table for Roche
Hargreaves Lansdown lists Roche with a market cap of 272.23 billion Swiss francs and a dividend per share of 9.80 francs. The same page shows an ex-dividend date of 12 March 2026 and a payment date of 16 March 2026. Hargreaves Lansdown Roche overview
What the market is weighing
Roche remains one of the heaviest names in the SMI, so the share price often reflects the tone of the Swiss index as much as company-specific news. On 26 June, MarketScreener also flagged a sector note on the Swiss pharma industry and a US trade investigation, which keeps the peer group in focus for investors. MarketScreener Swiss pharma note
All news and analysis on Roche shares
The topic page bundles Roche coverage, Swiss market data and related background material for readers who track the stock in Zurich.
Diagnostics and medicines
Roche earns most of its money from pharmaceuticals and diagnostics, with medicines such as Ocrevus and Tecentriq alongside its diagnostics franchises. Those businesses give the group a broad base, from oncology to testing equipment.
Roche shares at a glance
The Roche shares (CH0012032048) trade on 2026-06-26, 336.00 Swiss francs on Swiss Exchange.
Key data on Roche shares
- Company: Roche Holding AG
- ISIN: CH0012032048
- Ticker: ROG
- Trading venue: SIX Swiss Exchange
- Price (as of 2026-06-26): 336.00 CHF
- Market cap: 272.23 billion CHF (as of 2026-06-26)
- Sector / industry: Pharmaceuticals
- Index membership: SMI
- Next earnings date: not officially scheduled
Disclaimer: This article is for information only and does not constitute investment advice.
